Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioLine RX Ltd (NASDAQ:BLRX)

0.85
Delayed Data
As of May 25
 -0.0101 / -1.17%
Today’s Change
0.71
Today|||52-Week Range
1.42
-7.61%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$81.3M

Company Description

BioLineRx Ltd. is a clinical-stage biopharmaceutical company, which includes indentifying, in-licensing, and developing therapeutic candidates. Its in-licenses novel compounds, primarily from academic institutions and biotech companies based in Israel, and develops them through pre-clinical and clinical stages, and then partners with pharmaceutical companies clinical development and commercialization. The company was founded in April 2003 and is headquartered in Modi'in, Israel.

Contact Information

BioLineRx Ltd.
Modi'in Technology Park
Modi'in Tel Aviv 7177871
P:(728) 642-9100
Investor Relations:

Employees

Shareholders

Other institutional37.96%
Mutual fund holders0.52%
Individual stakeholders--

Top Executives

Philip Adam SerlinChief Executive Officer & Head-Investor Relations
Mali ZeeviChief Financial Officer
Abi Vainstein-HarasVice President-Clinical & Medical Affairs
Merril GerstenChief Scientific Officer
Nurit BenjaminiDirector & Compliance Officer